ANGIODYNAMICS INC (ANGO)
US03475V1017 - Common Stock
ANGO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. ANGO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ANGO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ANGO had negative earnings in the past year.
ANGO had a negative operating cash flow in the past year.
ANGO had negative earnings in 4 of the past 5 years.
In multiple years ANGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -59.22%, ANGO is not doing good in the industry: 74.48% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -87.96%, ANGO is doing worse than 64.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.22% | ||
| ROE | -87.96% | ||
| ROIC | N/A |
ROA(3y)-6.75%
ROA(5y)-8.2%
ROE(3y)-9.09%
ROE(5y)-10.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ANGO has a Gross Margin (50.17%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ANGO has remained more or less at the same level.
ANGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.31%
GM growth 5Y-1.33%
2. Health
2.1 Basic Checks
ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ANGO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ANGO has more shares outstanding
ANGO has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.77, we must say that ANGO is in the distress zone and has some risk of bankruptcy.
ANGO has a Altman-Z score of 0.77. This is comparable to the rest of the industry: ANGO outperforms 47.92% of its industry peers.
ANGO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.77 |
ROIC/WACCN/A
WACC10.01%
2.3 Liquidity
ANGO has a Current Ratio of 2.29. This indicates that ANGO is financially healthy and has no problem in meeting its short term obligations.
ANGO has a Current ratio of 2.29. This is in the lower half of the industry: ANGO underperforms 67.19% of its industry peers.
ANGO has a Quick Ratio of 1.62. This is a normal value and indicates that ANGO is financially healthy and should not expect problems in meeting its short term obligations.
ANGO has a Quick ratio of 1.62. This is in the lower half of the industry: ANGO underperforms 67.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
ANGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -342.86%.
The Revenue has decreased by -3.19% in the past year.
ANGO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.30% yearly.
EPS 1Y (TTM)-342.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-433.33%
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y8.64%
Revenue growth 5Y5.3%
Revenue growth Q2Q-6.85%
3.2 Future
The Earnings Per Share is expected to grow by 70.90% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.91% on average over the next years.
EPS Next Y-733%
EPS Next 2Y-190.09%
EPS Next 3Y25.99%
EPS Next 5Y70.9%
Revenue Next Year-15.1%
Revenue Next 2Y-7.87%
Revenue Next 3Y-2.43%
Revenue Next 5Y6.91%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ANGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ANGO's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-190.09%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
No dividends for ANGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ANGIODYNAMICS INC
NASDAQ:ANGO (4/30/2024, 9:28:24 AM)
5.6954
-0.12 (-2.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap228.10M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -59.22% | ||
| ROE | -87.96% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.17% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-342.86%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-733%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.19%
Revenue growth 3Y8.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y